Evidence map›Paper›PMID 35488897›Full record

ReviewAbdominal radiology (New York)2022

Schwannoma in and around the porta hepatis: radiological features in eight cases and literature review.

Moto Nakaya, Ryo Kurokawa, Takeyuki Watadani, Hiroyuki Morisaka, Maika Higuchi, Yusuke Toda, Hideki Kunichika, Masashi Kusakabe, Yoshitaka Okada, Yoshimitsu Ohgiya and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Annals of nuclear medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Moto NakayaDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Ryo KurokawaDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kuroro63@gmail.com.ORCID http://orcid.org/0000-0002-1186-8900
Takeyuki WatadaniDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Hiroyuki MorisakaDepartment of Diagnostic Radiology, Saitama Medical University International Medical Center, 1397-1 yamane, Hidaka-shi, Saitama, 350-1298, Japan.
Maika HiguchiDepartment of Radiology, Division of Radiology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Yusuke TodaDepartment of Radiology, Nihon University School of Medicine, 4-8-24 Kudan-Minami, Chiyoda-ku, Tokyo, 102-8275, Japan.
Hideki KunichikaDepartment of Radiology, Nara Medical University, 840 Shijo-cho, Kashihara, 634-8522, Japan.
Masashi KusakabeDepartment of Radiology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan.
Yoshitaka OkadaDepartment of Diagnostic Radiology, Saitama Medical University International Medical Center, 1397-1 yamane, Hidaka-shi, Saitama, 350-1298, Japan.
Yoshimitsu OhgiyaDepartment of Radiology, Division of Radiology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Masahiro OkadaDepartment of Radiology, Nihon University School of Medicine, 4-8-24 Kudan-Minami, Chiyoda-ku, Tokyo, 102-8275, Japan.
Hiroshi AnaiDepartment of Radiology, Nara City Hospital, 1-50-1 Higashikidera-cho, Nara, 630-8305, Japan.
Osamu AbeDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Manabu MinamiDepartment of Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan.
The University of Tokyo · JPNihon University · JPNTT Medical Center · JPSaitama International Medical Center · JPShowa University · JPNara City Hospital · JPNara Medical University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSchwannomas in and around the porta hepatis (porta hepatic schwannomas) are rare benign tumors easily misdiagnosed as other pathologies, including malignancies. We aimed to evaluate their imaging features on ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and

methodsWe performed a multi-institutional retrospective study by reviewing the clinical and imaging findings of pathologically proven eight porta hepatic schwannomas (mean age, 55 years; range, 38-80 years; one male and seven females). Preoperative imaging included three ultrasonography, eight CT, eight MRI, and two FDG-PET/CT.

resultsAll patients were asymptomatic. The mean tumor size was 61.9 mm (range, 30-180 mm), and all tumors demonstrated well-defined lesions on ultrasonography and their solid components showed soft tissue attenuation on non-contrast CT. MRI showed two distinct components in all cases: the component with T1-weighted hypointensities and T2-weighted hyperintensities with poor enhancement (suggestive of Antoni B histology); the component with T2-weighted hypointensities with gradually increasing enhancement (suggestive of Antoni A histology), resulting in a heterogeneous pattern on post-contrast CT or MRI (8/8, 100%). The separated deviation of surrounding bile ducts and vessels without obstruction allowed the recognition of extrahepatic localization and their benign nature. A ginger root-like morphology (2/8, 25%) seemed to be suggestive of extension along the Glisson's sheath, although this finding was not seen frequently.

conclusionRecognizing imaging features such as extrahepatic location, benign nature with internal structures suggestive of Antoni A/B histology, and characteristic tumor extension may provide key diagnostic clues for porta hepatic schwannomas.

Indexed as

Fluorodeoxyglucose F18NeurilemmomaFemaleHumansLiverMagnetic Resonance ImagingMaleMiddle AgedPositron Emission Tomography Computed TomographyRetrospective StudiesFluorodeoxyglucose F18Computed tomographyMagnetic resonance imagingPorta hepatisPositron emission tomographySchwannomaUltrasonography

Identifiers

PMID35488897
OpenAlexW4225117450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.